SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250357
Filing Date
2023-10-04
Accepted
2023-10-04 08:00:55
Documents
14
Period of Report
2023-10-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d539238d8k.htm   iXBRL 8-K 27066
2 EX-99.1 d539238dex991.htm EX-99.1 23950
6 GRAPHIC g539238g1004090003437.jpg GRAPHIC 3106
  Complete submission text file 0001193125-23-250357.txt   180648

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alxo-20231003.xsd EX-101.SCH 2862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20231003_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20231003_pre.xml EX-101.PRE 10820
8 EXTRACTED XBRL INSTANCE DOCUMENT d539238d8k_htm.xml XML 3290
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 231306592
SIC: 2834 Pharmaceutical Preparations